leadf
logo-loader
TSX-V:MDP OTCQX:MEDXF

Medexus Pharmaceuticals Inc

Receive alerts
Market:
TSX-V
Market Cap:
$142.99 m
Price
7.49 CAD
Change
6.70%
52 weeks high
9.75
52 weeks low
1.42

In brief

Medexus Pharmaceuticals, Inc. is a rapidly growing, commercial-stage specialty pharmaceutical company with an established presence across North America that is focused on an array of therapeutic areas, including rheumatology, auto-immune disease, specialty oncology and pediatrics.

Snapshot

Treosulfan is an innovative, orphan-designated agent developed for use as part of a conditioning treatment for patients undergoing allogeneic hematopoietic stem cell transplantation